BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Patient Worthy - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Patient Worthy
X-ORIGINAL-URL:https://patientworthy.com
X-WR-CALDESC:Events for Patient Worthy
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181112T100000
DTEND;TZID=America/New_York:20181112T110000
DTSTAMP:20260423T083613
CREATED:20181024T205717Z
LAST-MODIFIED:20181024T205717Z
UID:106903-1542016800-1542020400@patientworthy.com
SUMMARY:GlobalData's Orphan Drugs: A Review of Key Development Opportunities Webinar
DESCRIPTION:The Orphan Drugs: A Review of Key Development Opportunities Webinar\nInterested in learning the latest about orphan\, rare disease drug development? Well this is your opportunity. The orphan drug field has been getting more crowded as of late and shows no signs of slowing down. This presentation will feature presentations from GlobalData’s Journalist Team. \nThis webinar will focus on drug development for transthyretin amyloidosis (TTR)\, mucopolysaccharidosis (MPS)\, and atypical hemolytic uremic syndrome (aHUS). \nRegistration for this event is FREE.
URL:https://patientworthy.com/event/globaldatas-orphan-drugs-review-development-opportunities-webinar/
CATEGORIES:Amyloidosis,Atypical Hemolytic Uremic Syndrome,Mucopolysaccharide Diseases,Rare Disease
ORGANIZER;CN="GlobalData":MAILTO:tabatha.duff@globaldata.com
END:VEVENT
END:VCALENDAR